CIG vs ORA
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
CIG presents a classic 'value trap' profile, characterized by a weak Piotroski F-Score of 3/9 indicating deteriorating financial health despite trading significantly below its Graham Number ($3.96) and Intrinsic Value ($10.32). While the current P/E of 7.37 is attractive, the Forward P/E of 17.20 suggests a projected collapse in earnings. Furthermore, a dividend payout ratio of 96.83% is unsustainable and poses a high risk of cuts. The disconnect between deep value metrics and poor fundamental health/analyst 'underperform' ratings warrants a neutral stance.
ORA exhibits a stable financial foundation with a Piotroski F-Score of 6/9, yet it is trading at a massive premium compared to its Graham Number ($43.59) and Intrinsic Value ($14.14). While the company demonstrates strong top-line revenue growth (19.6%) and a stellar track record of beating earnings estimates, the negative YoY earnings growth (-24.4%) and an extreme PEG ratio of 4.54 indicate significant overvaluation. Liquidity is a primary concern with a current ratio of 0.81, and bearish insider activity further dampens the outlook despite a 'Buy' analyst consensus.
Compare Another Pair
Related Comparisons
CIG vs ORA: Head-to-Head Comparison
This page compares Companhia Energética de Minas Gerais - CEMIG (CIG) and Ormat Technologies, Inc. (ORA) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.